Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 493-497, April 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunii, A.
Right arrow Articles by Furth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunii, A.
Right arrow Articles by Furth, J.

Inhibition of Lymphoma Induction in Virus-infected Rats by Thymectomy. An Affinity of the Lymphoma Virus for Myeloid Cells*

Akira Kunii and Jacob Furth

( Department of Pathology, Columbia University-Francis Delafield Hospital, New York, New York)

Of 172 Sprague-Dawley rats infected with Gross passage virus at 2–3 days of age, 167 (97.1 per cent) died with thymic lymphoma, the males within 114 days (with a mean latency period of 75 days) and the females within 140 days (with a mean latency period of 80 days) after virus infection.

On the 114th day, when all male control rats were dead, 45 (70 per cent) of their siblings thymectomized at 30–35 days after virus infection were still alive, and 27 per cent were dead with either nonthymic lymphoma (thirteen rats) or myeloid leukemia (three rats) or both (one rat). At the termination of the experiment on the 170th day, 30 per cent of the thymectomized rats still gave neither gross nor microscopic evidence of leukemia. By this time the total incidence of leukemia in this group reached 59 per cent (12 per cent being myeloid).

Intense treatment of virus-infected female rats with doses of testosterone phenylacetate which caused slight thymic atrophy slightly inhibited the induction of thymic lymphoma by this virus. At termination of the experiment on the 170th day eleven of 115 rats of this group gave neither gross nor microscopic evidence of leukemia, whereas all of the 85 female control rats were dead within 140 days after virus infection and all but one with thymic lymphoma.

The experiments are interpreted as indicating an affinity of this virus for myeloid cells, though of lesser intensity than for thymic lymphoid cells. All of eight myeloid leukemias occurred in the virus-infected thymectomized group.

* This investigation was supported by Grant C-6215 of the National Cancer Institute.

Received 10/11/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.